CD8A and myeloid sarcoma: Genetic data further indicate that an enrichment of MS risk loci is identified in DNase hypersensitive sites (DHSs), i.e. associated with active transcription, in cell types of relevance for the MS disease, among them CD4+ and CD8+ T cells [34, 35].